Mod­er­na’s Covid and flu com­bo vac­cine suc­ceeds in Phase 3 study

Mod­er­na’s Covid-19 and in­fluen­za com­bi­na­tion vac­cine was com­pa­ra­ble to shots sep­a­rate­ly mar­ket­ed for the two in­fec­tions in a Phase 3 tri­al, the com­pa­ny an­nounced Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.